16
total announcements
519242.BO · 15 min delayed
Key Stats · Yahoo Finance · as of 04 Oct 2026
Market Cap
₹123 Cr
P/E (TTM)
24.6
EPS (TTM)
₹5.56
52W Low
₹59.95
52W High
₹174.65
Beta
-2.57
Price / Book
7.8
Debt / Equity
5.1
Revenue (TTM)
₹18 Cr
Gross Margin
23.63%
Operating Margin
-25.15%
Fresita Proteins Ltd
Fresita Proteins Ltd has issued a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, indicating compliance with the regulations.
Fresita Proteins Ltd
Fresita Proteins Ltd has released the Scrutinizer's Report for its Shareholder Meeting / Postal Ballot.
Fresita Proteins Ltd
Fresita Proteins Ltd has announced the outcome of its 35th Annual General Meeting (AGM), with details attached to the announcement.
Fresita Proteins Ltd
Fresita Proteins Ltd has announced the closure of its trading window for its directors, officers, and designated employees, indicating a potential material event or announcement is expected soon.
Fresita Proteins Ltd
Fresita Proteins Ltd clarifies the reason for the recent price movement in its shares.
Fresita Proteins Ltd
Fresita Proteins Ltd has received approval for a name change, with the new scrip ID to be effective from 21.09.2026.
Fresita Proteins Ltd
The BSE has sought clarification from Fresita Proteins Ltd regarding significant price movement to ensure investors have relevant information and to safeguard their interests.
Sarda Proteins Ltd
Sarda Proteins Ltd has scheduled a Board Meeting on 07/09/2026 to consider and approve various matters, including fixing the day for the purpose of providing the details of the book closure and the record date for the purpose of payment of dividend, if declared.
Sarda Proteins Ltd
Sarda Proteins Ltd announced the resignation of Gunvantray Jayantilal Zaladi from the post of Director, under Regulation 30 of the LODR.
Sarda Proteins Ltd
Sarda Proteins Ltd has announced that its board has approved the issue of equity shares on a right basis.
Sarda Proteins Ltd
Sarda Proteins Ltd's board has approved the issuance of equity shares on a rights basis for up to ₹10,000 lakhs.
Sarda Proteins Ltd
Sarda Proteins Ltd has submitted revised audited financial results for the quarter and financial year ended March 31, 2026, due to a variation in figures related to interest income and reclassification of share warrants as equity. The revised filing incorporates necessary corrections to the financial statements, which are deemed to be purely clerical and do not have a material impact on the company's overall financial position.
Sarda Proteins Ltd
Sarda Proteins Ltd has released a scrutinizer report for its EGM dated 30.07.2026, which is a routine procedural filing.
Sarda Proteins Ltd
Sarda Proteins Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 to consider and approve various matters.
Sarda Proteins Ltd
Sarda Proteins Ltd held an Extra-Ordinary General Meeting (EGM) on July 30, 2026, where several resolutions were passed, including increasing the authorized share capital, altering the main object clause, and changing the company's name to Fresita Proteins Limited.
Sarda Proteins Ltd
Sarda Proteins Ltd has announced a change in the company name from 'Sarda Proteins Limited' to a name approved by the Central Registration Centre (CRC), Ministry of Corporate Affairs, and alteration of the Memorandum of Association and Articles of Association.